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Triple-negative breast cancer, in which cells lack the 
expression of estrogen, progesterone, and human 
epidermal growth factor 2 receptors, is a clinical 
subtype of breast cancer commonly associated with 
poor prognosis. It tends to be aggressively metastatic 
with a high recurrence rate and little response to 
standard chemotherapy [1].  Mounting evidence 
suggests that one triggering event in oncogenic 
transformation is an imbalance in acid-base 
homeostasis, with an increase in intracellular pH and 
acidification of the extracellular tumor micro-
environment [2].  In breast cancer cells, intra-cellular 
pH is largely controlled by the action of the Na+/H+ 
exchanger isoform one (NHE1).  Previous reports show 
that excessive activity of the Na+/H+ exchanger triggers 
extracellular matrix proteolysis and promotes metastatic 
invasion by breast cancer cells [3]. We recently reported 
that this trigger of metastasis is critical in triple-negative 
breast cancer cells, but not as crucial in other types of 
breast cancer [4].  We generated an NHE1-knockout of 
MDA-MB-231 (triple-negative) breast cancer cells.  
The NHE1-knockout cells proliferated normally but had 
greatly reduced rates of migration and invasion in in 
vitro assays.  Growth of the knockout cells in xenograft 
tumor assays was also decreased dramatically compared 
to cells with the Na+/H+ exchanger.  Specific inhibition 
of exchanger activity in cells expressing NHE1 resulted 
in the increased efficacy of paclitaxel in promoting cell 
death and limiting rates of migration and invasion in 
different triple-negative breast cancer cells.  However, 
this effect was not seen in non-triple-negative breast 
cancer cells.  As a follow up, we directly examined the 
role of regulatory mechanisms responsible for the 
activation of NHE1 in metastasis [5].  Site-specific 
mutagenesis made an activated from of the Na+/H+ 
exchanger and this change promoted cell migration, 
invasion, and spheroid growth.  Mutation of the 
p90RSK phosphorylation site on NHE1’s cytosolic C-
terminal domain to a non-phosphorylatable amino acid 
altered the morphology of mesenchymal MDA-MB-231 
cells to a less invasive, epithelial-like phenotype 
compared to cells expressing wild-type NHE1.  
Notably, pharma-cological inhibition of p90RSK also 
inhibited the metastatic potential of invasive MDA-MB-
231 cells, but not of  non-invasive  Hs578T  triple-nega- 
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tive breast cancer cells.  
Overall, our data suggest that the Na+/H+ exchanger 
plays a key role in the metastasis of breast cancer cells.  
However, its function appears to be more critical in the 
invasive triple-negative breast cancer subtype.  We 
propose that it is the excessive activity of NHE1 during 
carcinogenesis that is essential in invasion and 
metastasis, and in promoting a change to a more 
invasive cell phenotype. While our data were supported 
by the examination of several triple-negative cell 
models, it is not yet known whether this occurs in most 
or all triple-negative cell types or if this observation can 
be exploited in therapy.  Additionally, while we 
demonstrated that p90RSK inhibition has beneficial 
effects in cells in culture, it is not clear if this inhibition 
of the Na+/H+ exchanger is a clinically viable prospect. 
Furthermore, NHE1 has multiple regulatory sites for 
kinase phosphorylation and interactions with 
intracellular protein and lipid binding partners. Many of 
these sites of regulation are not well defined in triple-
negative breast cancer cells, so that the call for further 
investigation remains.   
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